Hypoxia is not required for human endometrial breakdown or repair in a xenograft model of menstruation.
Level 5 - mechanism / opinion, no new human data
Bench and animal xenograft model with no direct human in vivo outcome measurements
PubMed 23729593 · doi:10.1096/fj.13-232074
What was done
Fragments of human functionalis endometrium were xenografted into ovariectomized immunodeficient mice supplemented with estradiol and progesterone pellets. Hormone withdrawal was induced 21 days post-grafting. Local partial oxygen pressure (pO2) was measured across hormone maintenance, withdrawal, and reimpregnation conditions using electron paramagnetic resonance with lithium phthalocyanine crystals and fluorescence quenching-based OxyLite probes. Tissue was also evaluated for hypoxia markers via HIF1-alpha immunostaining and pimonidazole adduct detection.
What was found
Hormone withdrawal induced tissue breakdown and MMP expression within 4 days. In mice with hormone maintenance, pO2 was low at 1 week post-grafting (14.8 ± 3.4 mmHg) and doubled from week 2 onward. After 3 weeks, pO2 was not altered by hormone withdrawal, whereas hormone reimpregnation 4 days post-removal slightly increased pO2 (34.7 ± 6.1 mmHg) compared to hormone maintenance (27.1 ± 8.6 mmHg). No significant HIF1-alpha immunostaining or pimonidazole adducts were detected after hormone withdrawal.
Why it matters
This study challenges the prevailing paradigm that spiral artery vasospasm-induced hypoxia is a necessary trigger for menstrual endometrial tissue breakdown and repair.
Limits
The study is limited to an ectopic xenograft model in immunodeficient mice, which may not fully replicate native human uterine architecture or spiral artery vasomotor control. The abstract does not state the number of mice or human tissue donors evaluated.
Cited by
- context In the days leading up to menstruation, a sharp drop in estrogen and progesterone cuts off blood supply to the endometrial lining, causing tissue ischemia and subsequent shedding.